p53 and ki67 Expression as Prognostic Factors for Cancer-Related Survival in Stage T1 Transitional Cell Bladder Carcinoma

By Rodrguez-Alonso A.   Pita-Fernandez S.   Gonzalez-Carrero J.   Nogueira-March J.L.  

European Urology, Vol. 41, Iss. 2, 2002-02 ,pp. : 182-189

Elsevier

Access to resources Recommend Favorite

Prognostic Value of MCM2 Immunoreactivity in Stage T1 Transitional Cell Carcinoma of the Bladder

By Kruger S.   Thorns C.   Stocker W.   Muller-Kunert E.   Bohle A.   Feller A.C.  

European Urology, Vol. 43, Iss. 2, 2003-02 ,pp. : 138-145

Elsevier

Access to resources Recommend Favorite

Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder

By Bol M.G.W.   Baak J.P.A.   Rep S.   Marx W.L.   Kruse A.J.   Bos S.D.   Kisman O.   Voorhorst F.J.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1124-1130

Elsevier

Access to resources Recommend Favorite

The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder

By Touloupidis Stavros   Fatles Georgios   Kalaitzis Christos   Giatromanolaki Alexandra   Sivridis Eythimyos   Simopoulos Konstantinos   Rombis Vassilios  

International Urology and Nephrology, Vol. 38, Iss. 2, 2006-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K.   Schultz M.   Stout P.   Fan K.  

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite